Category: Stock Report

VFH – VFH: Targeted QE To Balance High Inflation And Financial Stress

FED, federal reserve, Control interest rates, Inflation, Interest rates. World economy crisis, American economy and business concept. FED on Wooden block with Percentage sign and arrow up and down.

Wipada Wipawin/iStock via Getty Images

Only last month, things were looking good for the banks forming part of the Vanguard Financials ETF (NYSEARCA:VFH) which had broken the $88 resistance level. However, the second week of March changed it all with a drop to the $75-$76 level with a

INSP – Inspire Medical Systems: Sleep Apnea Equipment Specialist Looks Like A Buy

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

This article’s primary focus is on Inspire Medical Systems, Inc. (NYSE:INSP)

Investment Portfolio Discipline Summary

“Blockdesk’s Standard Performance Comparison fund invests in equities whenever Market-Maker hedging activity forecasts that 80% or more of the near-coming price

street analyst estimates

Yahoo Finance

MM hedging implied forecasts

blockdesk.com

detailed comparative data

blockdesk.com

trends of daily updated forecasts

blockdesk.com

PRIM – Primoris Services Corp: Promising Investment Opportunity, Strong Growth Prospects

Solar panels fields on the green hills

LeoPatrizi

Investment Thesis

Primoris Services Corporation (NASDAQ:PRIM) should see a boost in revenue in 2023, thanks to its strong order backlog levels and the recent acquisition of PLH. The company has secured $290 million worth of projects related to the construction

dcf valuation

DCF valuation (Created by DzD Analysis using Alpha Spread)

DON – DON: Higher Exposure To Financial And Real Estate Sectors Make It Vulnerable In 2023

Green Investing Piggy Bank with solar panels and Candlestick Graph

mphillips007

ETF Overview

Some may wonder whether to invest in large-cap, mid-cap or small-cap dividend funds. In this article, we will analyze WisdomTree MidCap Dividend ETF (NYSEARCA:DON) to see if it is a good investment choice among the

Chart

YCharts

Chart

YCharts

Chart

YCharts

Chart, sunburst chart Description automatically generated

WisdomTree Website

Chart

YCharts

PANW – Palo Alto Networks: A Smart Bet On AI-Backed Cybersecurity Business

Palo Alto Networks

hapabapa

Investment thesis

Palo Alto Networks (NASDAQ:PANW) is one of the most innovative artificial intelligence [AI] powered cybersecurity companies in the market. The company has achieved outstanding revenue growth over the past decade thanks to innovative cybersecurity solutions and high customer

PANW revenues by geography

Palo Alto Networks 10-Q

Disaggregatoin of PANW revenues

Palo Alto Networks 10-Q

PANW latest earnings summary

Seeking Alpha

FY 2023 guidance for PANW

Palo Alto Networks

PANW financials from 2013 to 2022

Compiled by author based on historical information

Chart
Data by YCharts
Chart
Data by YCharts
PANW SA valuation metrics

Seeking Alpha

PANW DCF scenario 1

Author’s calculations

PANW DCF scenario 2

Author’s calculations

FRC – First Republic Bank: Why I Am Sticking To My Investment

First Republic Bank Branch in New York City

Anne Czichos

A couple of things have happened to First Republic Bank (NYSE:FRC) since I submitted a contrarian call to buy the community bank’s shares about two weeks ago. FRC stock has whiplashed ever since and the bank

Source: JP Morgan

Source: JP Morgan

Source: First Republic Bank

Source: First Republic Bank

Source: First Republic Bank

Source: First Republic Bank

Chart
Data by YCharts
Chart
Data by YCharts

MSFT – Microsoft Plans To Use AI To Solve A Huge Pain Point For Doctors

Among the many challenges that physicians face, one of the most cumbersome is clinical documentation. In a study published by the Journal of Graduate Medical Education, it was found that nearly 92% of physicians surveyed reported that “documentation obligations are excessive,” and 73% reported that clinical documentation often has a negative impact on patient care.

The goal behind detailed clinical documentation is to ultimately ensure great record keeping: in an ideal world, a comprehensive patient chart enables any treating provider to see a patient’s entire medical and treatment history. Furthermore, the healthcare system has been built in such a way that documentation plays a critical administrative role. Healthcare organizations use patient charts to code and bill for services provided. Documentation also acts as a record of the patient journey, which has become especially important in the growing landscape of healthcare litigation.

However, for many providers, this is one of the most challenging aspects of the job, reporting that they spend far more time documenting a patient’s visit rather than with the patient itself.

This is a key pain point that technology companies are vigilant about, and now, Microsoft is working on a dynamic solution. Nuance Communications, which is owned by Microsoft, is the leader behind Dragon, one the healthcare industry’s most popular note dictation tools. The Dragon product is already well known as one of the best in class, boasting “voice recognition that’s 3x faster than typing with up to 99% accuracy,” in addition to flexibility of use, with easy synchronization across devices and systems.

Microsoft wants to leverage its work with AI and Chat-GPT to take this tool to the next level. In a press release earlier this week, Nuance expressed its commitment to increasing AI driven innovation, announcing “Dragon Ambient eXperience (DAX) Express, a workflow-integrated, fully automated clinical documentation application that is the first to combine proven conversational and ambient AI with OpenAI’s newest and most capable model, GPT-4…[as a means to] reduce administrative burden and empower clinicians to spend more time taking care of patients and less time on paperwork.”

The company explains that by employing “a unique combination of conversational, ambient, and generative AI, DAX Express automatically and securely creates draft clinical notes in seconds for immediate clinical review and completion after each patient visit in the exam room or via telehealth patient conversations. Clinicians will benefit from the seamless capabilities of Dragon Medical One, DAX, and DAX Express, which are tightly integrated into the electronic medical record, beginning from pre-visit through post-encounter, reducing cognitive burdens and helping increase the joy of practicing medicine.”

The value for this product will be determined by how accurately and seamlessly these draft clinical notes can be created, in an effort to ease physician workflows. The reality is that generative AI is actually quite accurate in a technical and objective sense; however, the key unlock in this space will be to ensure that the generated product is adaptive and easily modifiable by the provider for specific patient needs.

Scott Guthrie, Executive Vice President of the Cloud and AI Group at Microsoft, explained that “Microsoft and Nuance have been ahead of the curve in innovating AI solutions, and organizations large and small have long trusted our responsible, secure applications and infrastructure…With DAX Express, we are leveraging the revolutionary capabilities of large model AI to deliver outcomes-focused healthcare applications at scale.”

Indeed, if done correctly, Nuance and Microsoft have a lot to gain. More than just capturing market share, the companies have the potential to win the hearts and loyalty of millions of physicians that have to dedicate a significant portion of their day solely to cumbersome documentation practices.

Pundits are vivaciously expressing that with the introduction of generative AI, the next era of healthcare innovation is just around the corner. Undoubtedly, Microsoft has a massive opportunity with this technology, and has the potential to significantly improve healthcare delivery in a meaningful and tangible way.

KBWP – KBWP: Insurance ETFs Remain Resilient But Definitely Not Invincible

I rate the Invesco Exchange-Traded Fund Trust II – Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) a hold. However, I plan to follow this ETF during the coming periods as the high-strung emotions surrounding the financial sector begin to die

UNVR – SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Univar Solutions Inc. (NYSE: UNVR) and Encourages Investors to Contact the Firm

PHILADELPHIA, March 25, 2023 /PRNewswire/ — Kaskela Law LLC announces that it is investigating Univar Solutions Inc. (NYSE: UNVR) (“Univar”) on behalf of the company’s investors.

On March 14, 2023, Univar announced that it would be acquired by private equity firm Apollo at a price of $36.15 per share.  Following the closing of the proposed transaction, Univar investors will be cashed out of their investment position, and Univar’s shares will no longer be publicly traded. 

The investigation seeks to determine whether $36.15 per share provides UNVR shareholders with sufficient consideration for their shares, and whether Univar’s officers and/or directors breached their fiduciary duties in agreeing to sell the company at that price.

Univar shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email ([email protected] / [email protected]) or online at https://kaskelalaw.com/cases/univar-solutions/ , to receive additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.  This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740
www.kaskelalaw.com

SOURCE Kaskela Law LLC

CVT – SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cvent Holding Corp. (NASDAQ: CVT) and Encourages Investors to Contact the Firm

PHILADELPHIA, March 25, 2023 /PRNewswire/ — Kaskela Law LLC announces that it is investigating Cvent Holding Corp. (NASDAQ: CVT) (“Cvent”) on behalf of the company’s investors.

On March 14, 2023, Cvent reported that it would be acquired by private equity funds managed by Blackstone at a price of $8.50 per share.  Following the closing of the proposed transaction, Cvent investors will be cashed out of their investment position, and Cvent’s shares will no longer be publicly traded. 

The investigation seeks to determine whether $8.50 per share provides CVT shareholders with sufficient consideration for their shares, and whether Cvent’s officers and/or directors breached their fiduciary duties in agreeing to sell the company at that price.

Cvent shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email ([email protected] / [email protected]) or online at https://kaskelalaw.com/cases/cvent-holding-corp/ , to receive additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.  This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740
www.kaskelalaw.com

SOURCE Kaskela Law LLC